The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
We are striving to improve the lives of people with all types of cancer – including those with the most challenging to treat. With your support today, we can defeat cancer.
Cancer’s resistance to chemotherapy could be reversed by targeting lactate – the product that builds up as cancer cells convert nutrients to energy – according to new research published in Nature.
Tony McHale, a screenwriter, was invited to take part in the IMPACT study in 2012, an international clinical trial offering regular screening for men at increased risk of prostate cancer. Around 18 months later, he was diagnosed with the disease at the age of 61. After undergoing intense radiotherapy treatment, he has remained cancer-free ever since.
Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early – and after surgery and chemotherapy, he is now planning for the years ahead with his family. Here he tells his story and explains why more research into hard-to-treat cancers is so vital.
We aim to attract the best scientific minds who will be working at the forefront of cancer research, in an environment that’s collaborative, international and inclusive.
Our research is made possible by our generous community of donors and supporters. Help transform the lives of people with cancer.
We draw upon our excellent scientists and facilities to further our world-class cancer research. We work with funders to deliver major research centres and collaborations.
We are internationally renowned for driving scientific discoveries on cancer and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
Our competitive PhD programme is designed for the next generation of world-leading cancer researchers who will benefit from exceptional research facilities.
Help sustain our research into the future and improve the lives of more cancer patients, by making a regular donation.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.
The ICR-CTSU leads high-quality international cancer clinical trials, and their findings directly influence clinical practice within the NHS and worldwide.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
“Being involved in a clinical trial saved my life” – Tony’s story
“I’m lucky to have been given a second chance” – Michael’s story